There have been several updates to the Limited Coverage Drug Program for the treatment of Parkinson's disease. Limited coverage drugs are not generally considered to be first-line therapies or there are more cost-effective alternatives. To be eligible for...
Back for its 7th year, the annual Chocolate and Beer Tasting at Moody Ales is sure to satisfy the most sophisticated tastebuds. Explore small batch chocolates from Take a Fancy Chocolates paired with a brew from Moody Ales with flavourful and...
Parkinson Society British Columbia is proud to connect our community with the resources and tools they need to live well. Since Parkinson's disease (PD) can present differently in each individual, the Society endeavours to maintain impartiality when providing...
The first edition of the Canadian Guidelines on Parkinson’s Disease was published in 2012. The second edition, providing updates with input from healthcare professionals, people with Parkinson's, and Parkinson Canada, was released in September 2019. The...
In an effort to further expand our reach, Parkinson Society BC is pleased to announce a new collaboration with the Pacific Parkinson's Research Centre (PPRC). Beginning Thursday, October 3, 2019, we will be offering information and consultations to those...
To maximize the benefit of the Provincial Conference Moving Forward, Together to British Columbia's Parkinson's community, Parkinson Society British Columbia (PSBC) is offering a limited number of scholarships for people with Parkinson's (PWP) and family...
This September, thousands of participants across the country will gather together for Parkinson SuperWalk. This event is meant to empower the Parkinson's community and celebrate its resilience. No matter what the challenges, together we can make a difference....
If you've used Rasagiline (Azilect) or Selegline, we want your feedback. Safinamide (brand name Onstryv), which was approved in Europe in February 2015 and in the United States in March 2017, is indicated as an add-on therapy to a regimen that includes levodopa for...
Parkinson Society BC (PSBC) recently conducted a survey with the intent of better understanding the patient’s perspective in achieving symptom control with brand name (Sinemet) vs. generic forms of levodopa. The following is a summary of the 521 responses received:...
